{"id":256698,"title":"Notice - Release of guidance document: Regulatory framework for unauthorized new allergenic products of biological origin used for the diagnosis or treatment of allergic diseases - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T15:49:14.737000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulatory-framework-unauthorized-allergenic-products-biological-diagnosis-treatment-allergic-diseases.html","snippet":"Notice - Release of guidance document: Regulatory framework for unauthorized new allergenic products of biological origin used for the diagnosis or treatment of allergic diseases - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection…","rawSnapshotUrl":"/api/snapshots/raw/256698","browseUrl":"https://replay.healtharchive.ca/job-1/20250418154914/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulatory-framework-unauthorized-allergenic-products-biological-diagnosis-treatment-allergic-diseases.html#ha_snapshot=256698","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}